
Current Price | $28.18 | Mkt Cap | $410.0M |
---|---|---|---|
Open | $28.33 | P/E Ratio | 0.00 |
Prev. Close | $28.18 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $27.65 - $28.36 | Volume | 52,468 |
52-Wk Range | $19.95 - $32.51 | Avg. Daily Vol. | 88,350 |
The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
Current Price | $28.18 | Mkt Cap | $410.0M |
---|---|---|---|
Open | $28.33 | P/E Ratio | 0.00 |
Prev. Close | $28.18 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $27.65 - $28.36 | Volume | 52,468 |
52-Wk Range | $19.95 - $32.51 | Avg. Daily Vol. | 88,350 |
The best Bull and Bear pitches based on recency and number of recommendations.
The new approved drug is based on HRA, and is a one injection shot to the knee for osteoarthritis. I have taken HRA for years....It is a miracle drug.
Pending lawsuit with genzyme.declining marginsIncreased competition
Read the most recent pitches from players about ANIK.
Recs
Great financials, zero debt, under valued based on growth history and potential. High demand got content arthritis treatment and a growing market if baby boomers will expand that demand. More potential in European and global markets, and existing foreign subsidiaries.
Recs
Great fundamentals and a huge market for the products.
Recs
The new approved drug is based on HRA, and is a one injection shot to the knee for osteoarthritis. I have taken HRA for years....It is a miracle drug.
Find the members with the highest scoring picks in ANIK.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
mechming | < 20 | 12/7/2010 |
![]() |
5Y | $5.53 | +409.58% | +219.90% | +189.68 | 0 Comment | |
![]() |
acts20 | 41.02 | 9/30/2011 |
![]() |
NS | $5.41 | +420.89% | +244.47% | +176.41 | 2 Comments |
siri22 | < 20 | 9/1/2011 |
![]() |
NS | $6.00 | +369.67% | +224.22% | +145.45 | 1 Comment | |
CocaineOrStock | 93.95 | 7/15/2014 |
![]() |
5Y | $49.10 | -42.61% | +100.88% | +143.49 | 0 Comment | |
germantownrockvi | < 20 | 12/14/2010 |
![]() |
5Y | $6.20 | +354.52% | +217.83% | +136.69 | 0 Comment | |
vin100r | < 20 | 8/12/2011 |
![]() |
3W | $6.05 | +365.79% | +234.87% | +130.91 | 0 Comment | |
cerroalegre | < 20 | 12/15/2010 |
![]() |
5Y | $6.34 | +344.48% | +218.62% | +125.86 | 0 Comment | |
danculbertson | 59.59 | 8/10/2010 |
![]() |
5Y | $5.90 | +377.63% | +253.91% | +123.71 | 0 Comment | |
KidJones | 28.23 | 9/3/2013 |
![]() |
5Y | $23.47 | +20.07% | +139.96% | +119.89 | 0 Comment | |
mechincl | < 20 | 10/25/2010 |
![]() |
5Y | $6.33 | +345.18% | +232.79% | +112.39 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.